Literature DB >> 1653485

The Tat protein of equine infectious anemia virus is encoded by at least three types of transcripts.

S Noiman1, A Yaniv, T Tsach, T Miki, S R Tronick, A Gazit.   

Abstract

Nucleotide sequence analysis of a cDNA library of EIAV-infected canine cells established a complex pattern of gene expression, characterized by alternatively spliced polycistronic transcripts. The EIAV tat gene product was shown to be encoded by at least three species of mRNA which differed in their ability to trans-activate the EIAV LTR upon expression in canine cells. The most active cDNA was monocistronic, consisting of three exons. The most abundant cDNA in the library contained four exons and was identical to a polycistronic transcript previously described (Noiman et al., 1990b) which contains open frames for Tat, putative Rev, and truncated transmembrane proteins. Products consistent in size with those predicted for these last two proteins could be detected in in vitro translation experiments. The third Tat message, another four-exon form, also potentially encodes an amino terminally truncated transmembrane protein. In vitro mutagenesis experiments and analysis of subgenomic and partial cDNA clones confirmed and extended previous findings that S1 sequences are essential for trans-activation and that Tat translation initiates at a non-AUG codon either in the full-length Tat message or in the genomic S1 open reading frame. The Tat protein (8 kDa) was detected in cells transfected with a Tat cDNA construct and in canine cells persistently infected with EIAV. The Tat activity of polycistronic mRNAs was lower than that of the monocistronic form, suggesting that the expression of the EIAV trans-activator may be subject to several levels of posttranscriptional control.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1653485     DOI: 10.1016/0042-6822(91)90422-8

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  9 in total

1.  The surface envelope protein gene region of equine infectious anemia virus is not an important determinant of tropism in vitro.

Authors:  S T Perry; M T Flaherty; M J Kelley; D L Clabough; S R Tronick; L Coggins; L Whetter; C R Lengel; F Fuller
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

2.  Differential requirements for alternative splicing and nuclear export functions of equine infectious anemia virus Rev protein.

Authors:  M E Harris; R R Gontarek; D Derse; T J Hope
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

3.  Structural and functional characterization of rev-like transcripts of equine infectious anemia virus.

Authors:  R Rosin-Arbesfeld; M Rivlin; S Noiman; P Mashiah; A Yaniv; T Miki; S R Tronick; A Gazit
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

4.  Inhibitory activity of the equine infectious anemia virus major 5' splice site in the absence of Rev.

Authors:  W Tan; M Schalling; C Zhao; M Luukkonen; M Nilsson; E M Fenyö; G N Pavlakis; S Schwartz
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

5.  Equine infectious anemia virus trans-regulatory protein Rev controls viral mRNA stability, accumulation, and alternative splicing.

Authors:  L Martarano; R Stephens; N Rice; D Derse
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

6.  Translation of equine infectious anemia virus bicistronic tat-rev mRNA requires leaky ribosome scanning of the tat CTG initiation codon.

Authors:  R Carroll; D Derse
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

7.  Analysis of multiple mRNAs from pathogenic equine infectious anemia virus (EIAV) in an acutely infected horse reveals a novel protein, Ttm, derived from the carboxy terminus of the EIAV transmembrane protein.

Authors:  C E Beisel; J F Edwards; L L Dunn; N R Rice
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

8.  Equine infectious anemia virus gene expression: characterization of the RNA splicing pattern and the protein products encoded by open reading frames S1 and S2.

Authors:  R L Schiltz; D S Shih; S Rasty; R C Montelaro; K E Rushlow
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

9.  HIV-1 Tat Binding to PCAF Bromodomain: Structural Determinants from Computational Methods.

Authors:  Vo Cam Quy; Sergio Pantano; Giulia Rossetti; Mauro Giacca; Paolo Carloni
Journal:  Biology (Basel)       Date:  2012-08-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.